758P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic vulvar and vaginal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial.
Saved in:
| Title: | 758P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic vulvar and vaginal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial. |
|---|---|
| Authors: | Saint-Ghislain, M.1 (AUTHOR), Abdeddaim, C.2 (AUTHOR), Chaltiel, R.3 (AUTHOR), Cousin, S.4 (AUTHOR), Gomez-Roca, C.A.5 (AUTHOR), Borel, C.6 (AUTHOR), Ghiringhelli, F.7 (AUTHOR), Vansteene, D.8 (AUTHOR), Bigot, F.9 (AUTHOR), Jeannot, E.10 (AUTHOR), Guerini Rocco, E.11 (AUTHOR), Frige, G.12 (AUTHOR), Mazzarella, L.13 (AUTHOR), Francisco, M.14 (AUTHOR), Legrand, F.15 (AUTHOR), Jimenez, M.15 (AUTHOR), Halladjian, M.14 (AUTHOR), Kamal, M.16 (AUTHOR), Cabarrou, B.17 (AUTHOR), Le Tourneau, C.1 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS518-S518. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.1937 |
